Low-price drug nations catching ‘free ride’ on US innovation, report says
Amgen posts profit, says tax policy more effective than tariffs
Intuitive earns expanded FDA nod for da Vinci single port system
AstraZeneca’s triple-combo triumphs in two Phase III asthma trials
*please scroll down for all the latest news *
